Adipose Derived Mesenchymal Stem Cells (ADMSC) Lipogems®

Adipose Derived Mesenchymal Stem Cells (ADMSC) is beneficial for patients looking for a less invasive option to total joint replacement surgeries. In this procedure, adult mescenchymal stem cells are taken from the patient’s own adipose stores following the tendon or joint delivery protocol. An MRI scan may be used before beginning treatment in order to determine the primary pain generator. If the pain is generated from the joint, ADMSC is a good solution. In dealing with knee osteoarthritis,
if there are still progressive symptoms after traditional treatment course of intraarticular medications and biomechanical optimization with the use of an appropriate knee brace, further options should be considered. An innovative technique, Lipogems®, was developed to obtain microfragmented adipose tissue and Mesenchymal Stem Cells (MSC) with a high regenerative capacity. The Lipogems® technology was clinically available since 2013. Dr. McConnell is among the first in the area to bring this new regenerative medicine to orthopedic patients.